Researcher.Life Logo

Journal of the Egyptian National Cancer Institute : Impact Factor & More

eISSN: 2589-0409pISSN: 1110-0362
JournalOpen Access

Key Metrics

CiteScore
2.1
H-Index
26
SJR
Q3Oncology
SNIP
0.67
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of the Egyptian National Cancer Institute

Journal of the Egyptian National Cancer Institute Journal Specifications

Overview
Publisher SPRINGER
Language English
Frequency Continuous publication
Publication Time11
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorCairo University, National Cancer Institute
FrequencyContinuous publication
Publication Start Year2011
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 11
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in Journal of the Egyptian National Cancer Institute ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of the Egyptian National Cancer Institute

Overcoming barriers: mechanisms and strategies of nanoparticles in overcoming the blood-brain barrier and drug resistance in glioblastomas.
  • 18 May 2026
  • Journal of the Egyptian National Cancer Institute
Research status and challenges of anti-tumor effects of natural saponins and their combination therapy.
  • 18 May 2026
  • Journal of the Egyptian National Cancer Institute
Association of EGFR gene polymorphisms rs2072454 and rs2227983 with lung cancer susceptibility in a Western Algerian population: a case-control study.
  • 11 May 2026
  • Journal of the Egyptian National Cancer Institute
Nanomedicine against oxaliplatin-induced peripheral neuropathy: hypotheses and research perspectives on ion channels and immune microenvironment.
  • 11 May 2026
  • Journal of the Egyptian National Cancer Institute
MRI-based correlates of brain changes and quality of life outcomes following radiotherapy for head and neck cancer.
  • 4 May 2026
  • Journal of the Egyptian National Cancer Institute
Early cardiotoxicity of radiotherapy in breast cancer patients after chemotherapy: the early warning sign.
  • 27 Apr 2026
  • Journal of the Egyptian National Cancer Institute
Overcoming barriers: mechanisms and strategies of nanoparticles in overcoming the blood-brain barrier and drug resistance in glioblastomas.
  • 18 May 2026
  • Journal of the Egyptian National Cancer Institute
Research status and challenges of anti-tumor effects of natural saponins and their combination therapy.
  • 18 May 2026
  • Journal of the Egyptian National Cancer Institute
Association of EGFR gene polymorphisms rs2072454 and rs2227983 with lung cancer susceptibility in a Western Algerian population: a case-control study.
  • 11 May 2026
  • Journal of the Egyptian National Cancer Institute
Nanomedicine against oxaliplatin-induced peripheral neuropathy: hypotheses and research perspectives on ion channels and immune microenvironment.
  • 11 May 2026
  • Journal of the Egyptian National Cancer Institute
MRI-based correlates of brain changes and quality of life outcomes following radiotherapy for head and neck cancer.
  • 4 May 2026
  • Journal of the Egyptian National Cancer Institute
Early cardiotoxicity of radiotherapy in breast cancer patients after chemotherapy: the early warning sign.
  • 27 Apr 2026
  • Journal of the Egyptian National Cancer Institute

FAQs on Journal of the Egyptian National Cancer Institute